You may also like
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Herein, we review the current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexisting thrombotic disease who develop COVID-19, or those who need prevention or care for their thrombotic disease during the COVID-19 pandemic.
1 min read
Outcomes With Heparin-Induced Thrombocytopenia After Cardiac Surgery
Although uncommon, HIT is a highly morbid and potentially lethal complication, which should reinforce the importance of timely recognition and treatment of this adverse outcome.
1 min read
Septic Shock: When Full Flow is not Enough (EP Video)
Dr. Rodrigo Soto discusses ECMO and septic shock (26:46 minutes).
1 min read